Task: Answer the MCQ question.
Query: Which drug exhibits a -34.086% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CC1CCCN(C2=C(Cl)C(=O)N(c3cccc(Cl)c3)C2=O)C1
b) CN1CCN(/N=C/c2nc(-c3ccccc3Cl)n3ccccc23)CC1
c) C/C=C/CC#N
Answer: b. CN1CCN(/N=C/c2nc(-c3ccccc3Cl)n3ccccc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(/N=C/c2nc(-c3ccccc3Cl)n3ccccc23)CC1
CN1CCN(/N=C/c2nc(-c3ccccc3Cl)n3ccccc23)CC1
(E)-1-[3-(2-chlorophenyl)imidazo[1,5-a]pyridin-1-yl]-N-(4-methylpiperazin-1-yl)methanimine